PHILADELPHIA (CBS Local) — Some flea and tick medications can cause adverse reactions in dogs and cats, the U.S. Food and Drug Administration warned Thursday.READ MORE: Cherry Hill School District Psychologist Francesca Aldrich Helping Inspire, Connect Students Through Virtual Black History Month Book Club
Some animals receiving drugs in the isoxazoline class, including products sold under the brand names Bravecto, Nexgard and Simparica, have experienced adverse events such as muscle tremors, ataxia and seizures, the FDA says.
“Another product in this class, Credelio, recently received FDA approval. These products are approved for the treatment and prevention of flea infestations, and the treatment and control of tick infestations,” the FDA said in a statement.
While the FDA says the medications are still considered safe, it nevertheless issued an alert to owners and veterinarians.READ MORE: Mr. Potato Head Drops 'Mister' From Brand Name To Be More Gender Neutral
The FDA says it was also working with manufacturers of isoxazoline products to include new label information to highlight neurologic events.
“The agency is asking the manufacturers to make the changes to the product labeling in order to provide veterinarians and pet owners with the information they need to make treatment decisions for each pet on an individual basis,” the FDA said.Radnor School District Moves To Phase 1 Of COVID Plan, Full School Days For Kindergarten-5th Graders Begin Monday
The FDA says if your dog or cat experiences an adverse reaction, you should contact your veterinarian.